By vgreene, 20 June, 2019 Our editors also consult, as needed, with a board of clinical practitioners about specific clinical practices.
By vgreene, 20 June, 2019 Our editors review a variety of resources when creating and updating Epocrates drug monographs, such as FDA-approved product labeling (prescribing information), FDA review documents, pharmacotherapy texts, specialty references, clinical practice guideline
By vgreene, 20 June, 2019 If resources for adverse drug effect information improve, we’ll consider adding adverse-reaction incidence rates to future versions of Epocrates.
By vgreene, 20 June, 2019 Similarly, the cited adverse-effect incidence rates from one study can’t be directly compared with figures obtained from other studies involving different treatments, uses, or investigators.
By vgreene, 20 June, 2019 Adverse effect incidence rates derived from clinical trials can’t be accurately used to predict the frequency of adverse experiences in the course of usual medical practice, where patient characteristics and other factors may differ from those occurring d
By vgreene, 20 June, 2019 Tapping on a subclass title in this section allows you to view a list of product-specific monographs also assigned to this same subclass.
By vgreene, 20 June, 2019 Here's an example of how to use the Subclass (Alternatives) section in Epocrates through the "drug card":1. Launch the Epocrates app on your mobile device.2. Type "cephalexin" into the search bar at the top of the main screen and press Search.3. You’ll
By vgreene, 20 June, 2019 Here's an example of how to use the Subclass (Alternatives) section in Epocrates through the "drug card":1. Launch the Epocrates app on your mobile device.2. Type "cephalexin" into the search bar at the top of the main screen and press Search.3. You’ll
By vgreene, 20 June, 2019 Sometimes, a drug search in Epocrates on a mobile device may land on the “drug card” rather than the full Epocrates drug monograph.
By vgreene, 20 June, 2019 In this situation, tapping on the Subclass (Alternatives) section gives the option to view all drugs in the subclass(es) corresponding to where this particular drug is assigned.